These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

765 related items for PubMed ID: 11592079

  • 1. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G.
    Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
    [Abstract] [Full Text] [Related]

  • 2. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G.
    J Immunol; 2004 Jan 15; 172(2):954-63. PubMed ID: 14707068
    [Abstract] [Full Text] [Related]

  • 3. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G.
    J Immunol; 2002 May 01; 168(9):4531-7. PubMed ID: 11970999
    [Abstract] [Full Text] [Related]

  • 4. Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG.
    Hubert FX, Voisine C, Louvet C, Heslan M, Josien R.
    J Immunol; 2004 Jun 15; 172(12):7485-94. PubMed ID: 15187127
    [Abstract] [Full Text] [Related]

  • 5. Plasmacytoid dendritic cells: the key to CpG.
    Rothenfusser S, Tuma E, Endres S, Hartmann G.
    Hum Immunol; 2002 Dec 15; 63(12):1111-9. PubMed ID: 12480254
    [Abstract] [Full Text] [Related]

  • 6. Murine thymic plasmacytoid dendritic cells.
    Okada T, Lian ZX, Naiki M, Ansari AA, Ikehara S, Gershwin ME.
    Eur J Immunol; 2003 Apr 15; 33(4):1012-9. PubMed ID: 12672067
    [Abstract] [Full Text] [Related]

  • 7. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N, Kenney J, Jones J, Marshall J, Van Nest G, Dufour J, Bohm R, Lifson JD, Gettie A, Pope M.
    J Immunol; 2004 Aug 01; 173(3):1647-57. PubMed ID: 15265893
    [Abstract] [Full Text] [Related]

  • 8. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
    Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G.
    J Immunol; 2003 May 01; 170(9):4465-74. PubMed ID: 12707322
    [Abstract] [Full Text] [Related]

  • 9. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
    Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA.
    J Immunol; 2003 Oct 15; 171(8):4320-8. PubMed ID: 14530357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB.
    Eur J Immunol; 2003 Jun 15; 33(6):1576-85. PubMed ID: 12778475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
    Martinson JA, Tenorio AR, Montoya CJ, Al-Harthi L, Gichinga CN, Krieg AM, Baum LL, Landay AL.
    Immunology; 2007 Apr 15; 120(4):526-35. PubMed ID: 17343615
    [Abstract] [Full Text] [Related]

  • 16. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC.
    J Immunol; 1998 Sep 15; 161(6):3042-9. PubMed ID: 9743369
    [Abstract] [Full Text] [Related]

  • 17. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages.
    Sweet MJ, Campbell CC, Sester DP, Xu D, McDonald RC, Stacey KJ, Hume DA, Liew FY.
    J Immunol; 2002 Jan 01; 168(1):392-9. PubMed ID: 11751985
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 01; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.